期刊文献+

小剂量胺碘酮治疗室性心律失常疗效与QT间期的相关性 被引量:1

Correlation between efficacy of a low-loading dose of Amiodarone in the treatment of ventricular arrythmias and QT interval
下载PDF
导出
摘要 目的 :探讨小剂量胺碘酮治疗室性心律失常疗效与 QT间期的关系。方法 :4 8例室性心律失常患者给予小剂量胺碘酮 ,疗程 4个月 ,观察治疗前后患者室性心律失常有效控制率与 QT间期延长的关系以及不良反应。结果 :4 8例患者治疗有效率高达 90 % ,且维持量小 (14 3± 34m g/ d)。仅 1例出现一过性 T3、T4升高 ,余无其它不良反应。QT间期延长者治疗效果满意 ;QT间期未延长者 ,治疗效果不佳 ,经延长负荷期后可使部分患者 QT间期延长而取得满意疗效。结论 :小剂量胺碘酮治疗室性心律失常的疗效确切 ,维持用量小 ,不良反应少 ,且 QT间期延长者胺碘酮疗效较佳。 AIM: To evaluate the efficacy of a low-loading dose of Amiodarone in the treatment of ventricular arrythmias(VA). METHODS: Forty-eight patients with VA were treated with Amiodarone for four months. A low-loading dose of Amiodarone was given for fourteen days or more. The therapeutic efficacy, QT interval and side-effects were observe. RESULTS: The total effective rate of patients with VA was 89.6%. Only one patient developed hyperthyroidism and recovered after the treatment. No other side-effects due to Amiodarone were observed. The therapy was more effective in patients with QT interval prolongation. If VA was not controlled in patients with normal QT interval, QT interval was prolonged after additional loading dose of Amiodarone and VA was controlled. CONCLUSION: There was obvious therapeutic efficacy of a low-loading dose of Amiodarone in the treatment of ventricular arrythmias. No severe side-effects were found. The maintaining dose was lower. QT interval prolongation was very important for therapeutic efficacy.
出处 《心脏杂志》 CAS 2004年第2期135-136,139,共3页 Chinese Heart Journal
关键词 心律失常 室性 胺碘酮 QT间期 ventricular arrythmias Amiodarone QT interval
  • 相关文献

参考文献16

  • 1Julian DG, Camm AJ, Frangin G, et al. Randomized trial of effect of Amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction.. EMIAT[J].Lancet, 1997,349:667- 674.
  • 2Singh SN, Fletcher RD, Fisfker SG, et al. Amidarone in patients with congestive heart failure and asymptomatie ventricuiar arrhythmia[J].N Engl J Med, 1995,333 : 77- 82.
  • 3Kerin NZ, Aragon E, Faitel K, et al. Long-term efficacy and toxicity of high and low-dose Amiodarone regimens[J]. J Clin Pharrnacol, 1989, 29:418-423.
  • 4Cairns JA, Connolly SJ, Roberts RS, et al. Canadian Amiodarone myocardial infarction arrhythmia trial investigators. Randomizers trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarization :CAMIT[J]. Lancet, 1999, 353 : 9- 13.
  • 5Chuang CL, Chern MS, Chang SC, et al. Amiodarone toxicity in a patient with simultaneous involvement of cornea, thyroid gland, and lung[J]. Am J Med Sci, 2000,320(1):64-68.
  • 6Loh KC. Amiodarone-induced thyroid disorders: a clinical review[J]. Postgrad Med J,2000,76(893) :133- 140.
  • 7Doval HC, Nul DR, Grancelli HO, et al. Randomized trial of low-dose amidarone in severe congestive heart failure [J].Lancet, 1994,344 : 493- 498.
  • 8Vorperian VR, Havighurst TC, Miller S, et al. Adverse effects of low dose Amiodarone: a meta-anlysis[J].J Am Coll Cardiol,1997, 30(3):791-798.
  • 9Cairns JA, Connolly SJ, Roberts RS, et al. Canadian Amiodarone myocardial infarction arrhythmia trial investigators.Randomizeds trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarization:CAMIT
  • 10Julian DG, Camm AJ, Frangin G, et al. Randomized trial of effect of Amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT[J]. Lancet,1997,349:667-674.

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部